GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » NexgenRx Inc (TSXV:NXG) » Definitions » Research & Development

NexgenRx (TSXV:NXG) Research & Development : C$0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is NexgenRx Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. NexgenRx's Research & Development for the three months ended in Dec. 2023 was C$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.00 Mil.

NexgenRx Research & Development Historical Data

The historical data trend for NexgenRx's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NexgenRx Research & Development Chart

NexgenRx Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

NexgenRx Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

NexgenRx Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NexgenRx  (TSXV:NXG) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

NexgenRx Research & Development Related Terms

Thank you for viewing the detailed overview of NexgenRx's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

NexgenRx (TSXV:NXG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » NexgenRx Inc (TSXV:NXG) » Definitions » Research & Development
Comparable Companies
XCNQ:ACRG.A.U XCNQ:AYR.A TSXV:HASH XCNQ:GRIN TSXV:RX TSXV:MPH TSXV:LOVE TSXV:DHB TSX:MDP TSXV:CANB UNH ELV CVS CI HUM CNC MOH OSCR SZSE:000503 ALHC
Traded in Other Exchanges
NEGXF:USA
Address
191 The West Mall, Suite 905, Toronto, ON, CAN, M9C 5L6
Website
http://www.nexgenrx.com
NexgenRx Inc administers, adjudicates and pays drug, dental and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers using proprietary computer software and provides ancillary services. Some of the products and services of the company are Dental Claims, Prescription Drug Claims and many more.
Executives
Paul Crossett 10% Security Holder